Skip to main content
Top
Published in: Virology Journal 1/2021

Open Access 01-12-2021 | Hepatitis A | Case Report

Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism

Authors: Natália Lima Pessoa, Aline Almeida Bentes, Andrea Lucchesi de Carvalho, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Erik Vinicius de Sousa Reis, Tayse Andrade Rodrigues, Erna Geessien Kroon, Marco Antônio Campos

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Background

Covid-19 has the respiratory tract as the main target of infection, and patients present mainly dyspnea, pneumonia, dry cough, and fever. Nevertheless, organs outside the respiratory tract had been reported in recent studies, including the gastrointestinal tract and liver. The host innate immune system recognizes pathogen-associated molecular patterns (PAMPs) through their pattern recognition receptor (PRRs). Toll-like receptor 7 (TLR-7) is a pattern recognition receptor recognizing ssRNA (SARS-CoV-2 is an ssRNA). Polymorphisms are characterized by two or more alternative forms of a distinct phenotype in the same population. Polymorphisms in tlrs genes can negatively influence the immune response to infectious diseases. There are several references in the literature to non-synonymous single nucleotide (rs) polymorphisms related to several genes. Some of them are important for the innate immunity, as rs 179008 (tlr-7), rs3775291 (tlr3), rs8177374 (tir domain-containing adaptor protein, tirap), rs1024611 (monocyte chemoattractant protein-1, mcp-1) and rs61942233 (2-5-oligoadenylate synthase-3, oas-3).

Case presentation

We identified a 5-year-old-male child with gastrointestinal symptoms and fever presenting acholic stool and jaundice, who was positive for SARS-CoV-2 IgM, IgA, and IgG and presenting the Gln11Leu rs 179008 in tlr-7. The child presented high levels of aspartate aminotransferase, alanine aminotransferase, bilirubin, C-reactive protein, D-dimer, gamma-glutamyl transferase, alkaline phosphatase, and was negative for serological tests for hepatitis A, B, C, E, HIV 1 and 2, herpes virus, cytomegalovirus, Epstein–Barr virus, and negative for RTqPCR for Influenza A and B, RSV and SARS-CoV-2. We also investigated other SNPs in the tlr-3 (rs3775291), tirap (rs8177374), mcp-1 (rs1024611), and oas-3 (rs61942233) genes, and no mutation was detected. After an interview with the child's caregivers, any possible accidental ingestion of drugs or hepatotoxic substances was ruled out.

Conclusion

To our knowledge, this is the first report of a SARS-CoV-2 caused hepatitis in a male child that has the tlr-7 Gln11Leu rs 179008, which could impair an efficient initial immune response. The knowledge of the patient's immune deficiency could improve the treatment to correct this deficiency with specific medications.
Literature
1.
go back to reference Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.CrossRef Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.CrossRef
2.
go back to reference Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–30.CrossRef Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–30.CrossRef
3.
go back to reference Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40:998–1004.CrossRef Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40:998–1004.CrossRef
4.
go back to reference Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.CrossRef Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.CrossRef
5.
go back to reference Liu BM, Hill HR. Role of host immune and inflammatory responses in COVID-19. Cases with underlying primary immunodeficiency: a review. J Interferon Cytokine Res. 2020;40:549–54.CrossRef Liu BM, Hill HR. Role of host immune and inflammatory responses in COVID-19. Cases with underlying primary immunodeficiency: a review. J Interferon Cytokine Res. 2020;40:549–54.CrossRef
6.
go back to reference Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7:131–7.CrossRef Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7:131–7.CrossRef
7.
go back to reference Mukherjee S, Huda S, Babu SPS. Toll-like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol. 2019;90:e12771.CrossRef Mukherjee S, Huda S, Babu SPS. Toll-like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol. 2019;90:e12771.CrossRef
8.
go back to reference van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663–73.CrossRef van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324:663–73.CrossRef
9.
go back to reference Fakhir FZ, Lkhider M, Badre W, Alaoui R, Meurs EF, Pineau P, et al. Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Liver Int. 2017;38:432–42.CrossRef Fakhir FZ, Lkhider M, Badre W, Alaoui R, Meurs EF, Pineau P, et al. Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Liver Int. 2017;38:432–42.CrossRef
10.
go back to reference Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, et al. SARS-CoV-2 transmission among children and staff in daycare centers during a nationwide lockdown in France: a cross-sectional, multicenter, seroprevalence study. Lancet Child Adolesc Health. 2021;S2352–4642(21):00024–9. Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, et al. SARS-CoV-2 transmission among children and staff in daycare centers during a nationwide lockdown in France: a cross-sectional, multicenter, seroprevalence study. Lancet Child Adolesc Health. 2021;S2352–4642(21):00024–9.
11.
go back to reference Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–4.PubMedPubMedCentral Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–4.PubMedPubMedCentral
12.
go back to reference Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. J Ann Intern Med. 2020;173:262–7.CrossRef Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. J Ann Intern Med. 2020;173:262–7.CrossRef
Metadata
Title
Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism
Authors
Natália Lima Pessoa
Aline Almeida Bentes
Andrea Lucchesi de Carvalho
Thaís Bárbara de Souza Silva
Pedro Augusto Alves
Erik Vinicius de Sousa Reis
Tayse Andrade Rodrigues
Erna Geessien Kroon
Marco Antônio Campos
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01656-3

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine